Rett Syndrome Clinical Trial
Official title:
Search for New Genes Involved in Molecular Etiology of Rett Syndrome Through Comparative Genomic Hybridization on DNA Microarrays
Rett syndrome (RTT) is a genetic encephalopathy and the typical form is caused by mutations
in the gene MECP2. It is a genetically heterogeneous pathology. CDKL5 and FOXG1 have been
recently discovered being involved in other forms of RTT. However, at least 5% of typical
forms and more other atypical forms are not linked to any of 3 genes known to be involved in
the disease.
The purpose of this study is to identify new genes involved in molecular etiology of typical
and atypical forms of RTT.
Search for pathogenic chromosomal imbalance through comparative genomic hybridization (aCGH)
on DNA microarrays will be done in a group of patients having typical or atypical forms of
RTT without known mutations in MECP2, CDKL5 et FOXG1B genes.
After imbalance confirmation by qPCR, the pathogenic potential of the segmental aneusomy
will be assigned according to the interpretation of aCGH technique-dedicated DECEPHER, BACH
and GVD databases. Analysis of parents will allow distinguishing between inherited
polymorphic variants and potentially deleterious new imbalances.
In case of a new imbalance, a bioinformatics approach will look for candidate genes that
will be possibly confirmed by classic mutation screening (sequencing and PCR) in all typical
and atypical cases of RTT present in the cohort.
The identification of new genes involved in RTT will ameliorate the molecular diagnosis of
the disease and genetic counseling for families. This project will allow progression in
comprehension of physiopathological mechanisms of cerebral development abnormalities
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04988867 -
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
|
Phase 2/Phase 3 | |
Recruiting |
NCT00069550 -
Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome
|
Phase 3 | |
Enrolling by invitation |
NCT06139172 -
Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities
|
N/A | |
Not yet recruiting |
NCT04014985 -
Patients With RETT Syndrome
|
N/A | |
Not yet recruiting |
NCT04041713 -
A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome
|
Phase 2 | |
Completed |
NCT02705677 -
Biobanking of Rett Syndrome and Related Disorders
|
||
Terminated |
NCT02790034 -
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
|
Phase 2/Phase 3 | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Recruiting |
NCT05932589 -
Neurophysiologic Biomarkers in Rett Syndrome
|
||
Recruiting |
NCT04463316 -
GROWing Up With Rare GENEtic Syndromes
|
||
Completed |
NCT04776746 -
Open-Label Extension Study of Trofinetide for Rett Syndrome
|
Phase 3 | |
Completed |
NCT04181723 -
Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDERâ„¢)
|
Phase 3 | |
Enrolling by invitation |
NCT03836300 -
Parent and Infant Inter(X)Action Intervention (PIXI)
|
N/A | |
Completed |
NCT04514549 -
ASSESSING EMERALD AND MC10 BIOSTAMP nPOINT BIOSENSORS FOR RETT SYNDROME
|
||
Terminated |
NCT02562820 -
An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome
|
Phase 1 | |
Completed |
NCT02738281 -
Natural History of Rett Syndrome & Related Disorders
|
||
Completed |
NCT05687214 -
Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome
|
N/A | |
Recruiting |
NCT06199700 -
Esketamine for the Treatment of Rett Syndrome
|
Early Phase 1 | |
Completed |
NCT03941444 -
ANAVEX2-73 Study in Patients With Rett Syndrome
|
Phase 3 | |
Recruiting |
NCT06346106 -
The Diagnostic Experience of Male Rett Syndrome
|